Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy.

In the tamoxifen-treated group, Bcl-2 positivity was also significantly correlated with poor OS among patients with hormone receptor-negative or triple-negative tumors, but that did not reach statistical significance in DFS, probably due to the small number of cases in that group (Fig. 3 ).

also in 111,027 other papers